Sunday, June 14, 2020

HGEN's Covid "Cure"

HGEN 4.08, which should easily be in double digits Monday, late after the close Friday released results of the  Mayo Clinic Compassionate use study of Lenzilumab in 12 patients, that had SIGNIFICANT co-morbidities, (diabetes, hypertension, obesity, obstructive lung disease, and kidney and lung disease) with a median time to discharge of 5 days. This data crushed Gilead's Remdesivir's data.

A couple weeks ago Asta Zeneca approached Gilead in a $100 billion takeover...Maybe its bankers should think smaller companies, instead of larger fees but I digress...

There were no treatment-emergent adverse advents, and no mortality in patients with severe and critical COVID-19 pneumonia.

Sometimes, when you want results, like against this "invisible enemy" you need to get people that can get things done. It worked in the "Dirty Dozen" script against the Nazi's in World War II which was Hollywood's version on the so-called suicide mission of the "Filthy Thirteen."  They were paratroopers who went behind enemy lines blowing up a bridge in the Invasion of Normandy and did reconnaissance (spying) before the Battle of The Bulge.

And like the HGEN Covid 12 trial, none of them died.

Only the enemy.

Monday, June 8, 2020

Draftkings! Giving you a chance to buy it!

Draftkings DKNG 36.85 has pulled back from 45. It's software in the cloud-and sports are coming on deck! You got all the pullback your are going to get! Take the stock and the cheap June 19 42 calls at $1.2! BOOM!!

Thursday, June 4, 2020

Portnoy--The next Titan on Wall Street


and now


In the pre-market on March 19, 2019 I bought 500 shares of PENN

03/19/2020 09:21:29 Bought 454 PENN @ 4.95 -2,247.30
03/19/2020 09:21:29 Bought 46 PENN @ 4.9 -225.40

But some some stupid suit started selling at the opening--So I bought 400 more

03/19/2020 09:46:00 Bought 200 PENN @ 4.075 -815.00 
03/19/2020 09:46:57 Bought 200 PENN @ 4.1 -820.00 

And then I said to myself--This is the bottom. Let me make it an even 1,000. So I bought another 100

03/19/2020 10:06:34 Bought 100 PENN @ 5.31 -531.00 

Why was it the bottom? Because at a nice bottom, there's competition! And you can't get all you want but just what you need!

So you always have these dreamers that WISH they bought Apple at the bottom, or Facebook after Barron's panned it at 19, or Amazon at 6, or Tesla when Wall Street hated it.

So I bought PENN. At the bottom. It's at 37 and change, and the bears are squawking. Squawk at me when it's 100. Then squawk at me at $200. Portnoy, gives live trading that's real. Not Wall Street bullshit where analysts talk the trading position of the firm and couch their recommendations to screw people. "Stay in your lane, Suit!"

And one day, Portnoy will make an announcement. "I'm worth a billion." He's a hundo. Do the math. With your extra big brain. Doesn't PENN have to get to 300? 

So why would you sell?

But let's look at a suit.

The revered so called "Oracle of Omaha." Sorry but his best days are past. Buffett is more worried about giving money to Planned Parenthood to cull the population, when he is at the culling floor himself. You think he can make any decisions with a clear head when he's sweating the grim reaper and he doesn't have an ally in the White House to bail him out?

Buffett made the single largest best bet ever throwing $36 billion in Apple. So at one time he had big balls. But does anyone remember Buffett puking up the airlines?

Warren Buffett: Why we sold our entire stakes in American, Delta ...

At the virtual annual of Berkshire Hathaway Old Man Buffett was looking worried about Covid, and wearily and haggardly he explained how with $137 billion of cash he didn't buy a share of stock when the market crashed, and SOLD EVERY SHARE OF ALL HIS AIRLINES and puked up Goldman Sachs.

Meanwhile Portnoy was touting SAVE at 7, and NCLH at 10. When SAVE was around 8 "He said he saw this song and dance... If I lose a be it!"  "If you can't handle the heat, get out of the kitchen..with your goody two shoes stocks." 

Go Google it. It was May 7th. He shoved those stocks, at the bottom up Wall Street's lying ass. At the bottom. Let me repeat. He shoved those stocks up Wall Street's ass at the bottom! 

So SAVE is now at 21. NCLH at 19.59. 

And PENN?  $37.37. I think it rips the shorts apart. 55 by the time basketball starts.

Do you need a reason? There's probably 20 million short on PENN, 25 million short on SAVE and 40 million short on NCLH.  Do you really thing these shorts have a chance? Give me a break!
Those shorts are going to get blown up.

Because it's the quarantine market. It goes up and keeps all the so called smart money out. And all the shorts keep shorting thinking the market will collapse. 

The suits, Buffett and shorts are locked out. 

They are quarantined! 

While the so called dumb money Robinhood accounts and the DDTG Portnoy day traders are ripping their heads off. As it should be!

"Stay in your lane, Suit!"

Tuesday, June 2, 2020

Martin Shrekil gets sentenced by Wall Street

Humanigen (HGEN 1.65) announced a $72 MILLION raise today led by JPM Securities and a stream of notable health care investors:

Net proceeds from the financing will be used to fund development of the company's monoclonal antibody portfolio and for general corporate purposes, including the pivotal Phase III trial of lenzilumab for the prevention and treatment of cytokine storm in COVID-19 pneumonia and the development of Humanigen's pipeline, including ZUMA-19, the CAR-T study involving lenzilumab being conducted in collaboration with Kite Pharma/Gilead Sciences.

Dr. Cameron Durrant, chief executive officer of Humanigen, stated, "We are pleased to announce this financing that incorporates some of the most respected and knowledgeable specialized healthcare investors in the world. We appreciate our new investors' validation of Humanigen's approach to GM-CSF pathway science and its potential impact in COVID-19 patients, as well as other conditions with high unmet medical need. With the support of our existing and new investors, we are also planning to list our common stock on a national securities exchange in the coming months."

The irony.

The whole sag on KalBios post Bankruptcy has been delightfully written up here. Notably we have this:

[What a sweet irony it would work, should all of this play out in the favor of those investors burned by Martin, since long ago he was required to divest all his holdings in what became Humanigen. But back to the story, proper, then:]

One of the programs Dr. Durrant has pursued since the company was freed of Martin via a bankruptcy reorganization, involved… Lenzilumab.

Here is a bit from the top of page 78 of the just filed Humanigen SEC Form 10-K, related to the at least animal model studies of Lenzilumab:

“…Recent data from China and the subject of a pre-publication titled “Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus”, supports the hypothesis that cytokine storm-induced immune mechanisms have contributed to patient mortality with the current pandemic strain of coronavirus.

The severe clinical features associated with some COVID-19 infections result from an inflammation-induced lung injury requiring Intensive Care Unit (ICU) care and mechanical ventilation. This lung injury is a result of a cytokine storm resulting from a hyper-reactive immune response. The lung injury that leads to death is not directly related to the virus, but appears to be a result of a hyper-reactive immune response to the virus triggering a cytokine storm that can continue even after viral titers begin to fall.

How did HGEN raise $72 million almost overnight?

Check their SEC filing here.

And then check this out.

BURLINGAME, CA / ACCESSWIRE / June 1, 2020 / Humanigen, Inc., (HGEN) ("Humanigen"), a clinical stage biopharmaceutical company focused on preventing and treating cytokine storm with lenzilumab, the company's proprietary Humaneered® anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody, today announced that Dr. Cameron Durrant, the company's chief executive officer, and Dr. Dale Chappell, the company's chief scientific officer, will present at the Jefferies 2020 Virtual Global Healthcare Conference on Thursday, June 4, 2020 at 3:00 p.m. ET in Virtual Track Room 7.

Maybe another Covid Cure?

Remember Shrekil was DENIED an early release to help with a Covid Cure. Shrekil wanted only a three month "furlough." Well they took away his cell phone from prison--did Pharma Boy know something good was cooking--in the company that he was forced out and sold?

And now KalBios--renamed, revamped and now recapitalized as  Humanigen--the old vehicle that "Pharma boy" screwed people--Do they have something good?

Wouldn't it be ultimate Wall Street irony if it played out that way?

Martin gets screwed and his investors that Shrekli screwed, now get paid!

Wall Street justice!